Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Mouse C3/Complement C3 Polyclonal Antibody

Catalog #:   PMB89901 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, IF, WB
Accession: P01027
Overview

Catalog No.

PMB89901

Species reactivity

Mouse

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Mouse C3/Complement C3 (Leu1000-Val1286).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, IF: 1:50-1:100, WB: 1:1000-1:4000

Target

Complement C3, HSE-MSF, Complement C3 beta chain, C3-beta-c, C3bc, Complement C3 alpha chain, C3a anaphylatoxin, Acylation stimulating protein, ASP, C3adesArg, Complement C3b alpha' chain, Complement C3c alpha' chain fragment 1, Complement C3dg fragment, Complement C3g fragment, Complement C3d fragment, Complement C3f fragment, Complement C3c alpha' chain fragment 2, C3

Purification

Purified by antigen affinity column.

Accession

P01027

Applications

ELISA, IHC, IF, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with C3/Complement C3 antibody (PMB89901) at 1 µg/ml.

    Lane 1: Recombinant Protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 34 kDa
    Observed MW: 34 kDa
References

A case report and literature review on new-onset systemic lupus erythematosus leading to thrombocytopenia in a hemodialysis patient., PMID:40527778

Advanced breast cancer immunotherapy: Surface modification of NK cells for embedding antibody-drug conjugates., PMID:40527034

Metabolic profiling of glioblastoma and identification of G0S2 as a metabolic target., PMID:40519301

Common Toll-like receptor 7 variants define disease risk and phenotypes in juvenile-onset systemic lupus erythematosus., PMID:40516124

Immunotherapy Platform That Conjugates Antigen to Complement C3-Targeted Liposomes Induces a Robust Adaptive Immune Response., PMID:40507796

An Unusual Presentation of Bullous Skin Lesions During Pregnancy., PMID:40503690

Effects of C3aR activated mast cells in eosinophilic esophagitis., PMID:40502038

A Rare Case of Warm Autoimmune Hemolytic Anemia With Intravascular Hemolysis: A Case Report., PMID:40497195

Lecanemab Binds to Transgenic Mouse Model-Derived Amyloid-β Fibril Structures Resembling Alzheimer's Disease Type I, Type II and Arctic Folds., PMID:40495448

Primary Sjögren's syndrome presenting with non-diffuse membranoproliferative glomerulonephritis-like lesions in cryoglobulinemic glomerulonephritis: a case report., PMID:40491909

Correlation study between clinical phenotypes and autoantibodies in systemic sclerosis in Southwest China., PMID:40489831

Elevated eosinophil-to-lymphocyte ratio (ELR) as a predictor of relapse for IgG4-related disease: a retrospective study across a decade., PMID:40488799

Dual Autoimmunity: A Case Report of the Sequential Development of Systemic Lupus Erythematosus in a Patient With Anti-MDA5 Dermatomyositis., PMID:40486387

[Diagnosis, treatment, and genetic analysis of five cases of primary atypical hemolytic uremic syndrome]., PMID:40484823

Clinical and immunopathological assessment of the oral mucosa in coeliac disease: a pilot study., PMID:40483462

Post-infectious glomerulonephritis among children before and during the COVID-19 pandemic., PMID:40478486

Complement in anti-glomerular basement membrane glomerulonephritis., PMID:40469278

Analysis of human factor H-related gene and protein expressed in rheumatoid arthritis synovium identifies a novel mechanism promoting dysregulated complement pathway activation., PMID:40467630

Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates., PMID:40458186

Streptococcus suis AdcA interacts with factor H and inhibits C3b deposition on the bacteria to participate in complement evasion., PMID:40446560

Hemolytic uremic syndrome in severe acute pancreatitis., PMID:40443860

Host complement C3 promotes malaria transmission by killing symbiotic bacteria in the mosquito midgut., PMID:40434644

Activated Immune and Complement C3 Are Potential Contributors in MASH via Stimulating Neutrophil Extracellular Traps., PMID:40422243

Insights into the recognition mechanism of shark-derived single-domain antibodies with high affinity and specificity targeting fluoroquinolones., PMID:40417246

Associations between biological markers and haematological manifestations in patients with systemic lupus erythematosus., PMID:40414271

Competitive electrochemiluminescence immunosensor based on self-deposited ultrasmall Ru nanoparticles on g-C3N4 and luminol for H-FABP detection., PMID:40410428

Diagnostic value of blood coagulation index in obstetric antiphospholipid syndrome and its subtypes., PMID:40409231

TLR7 responses in glomerular macrophages accelerate the progression of glomerulonephritis in NZBWF1 mice., PMID:40401698

Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ductal adenocarcinoma., PMID:40394523

Ultrasensitive Electrochemiluminescence Immunosensor of Procalcitonin Based on Synergistic Enhancement by Hf-MOF/g-C3N4 via Integration of Dual Luminophores, a Coreactant Accelerator, and Energy Transfer., PMID:40388807

Expanding the spectrum of genetic causes of DNA-specific exonuclease TREX1 variants in thrombotic microangiopathy., PMID:40383229

The 4 functional segments of Factor H: Role in physiological target recognition and contribution to disease., PMID:40356067

Efficacy and safety of belimumab versus rituximab for refractory immune thrombocytopenia in patients with connective tissue disease., PMID:40355343

Advancements in Complement Inhibition for PNH and Primary Complement Mediated Thrombotic Microangiopathy., PMID:40354320

Umbilical cord mesenchymal stem cell-derived secretome as a potential treatment for systemic lupus erythematosus: A double-blind randomized controlled trial., PMID:40352183

Application of machine learning for the analysis of peripheral blood biomarkers in oral mucosal diseases: a cross-sectional study., PMID:40348983

Immunoglobulin a vasculitis with central nervous system involvement: analysis of 10 cases., PMID:40346320

Characterization of anti-neutrophil extracellular traps (NET) antibodies according to systemic lupus erythematosus clinical phenotypes., PMID:40343598

Thrombospondin-1 inhibits alternative complement pathway activation in antineutrophil cytoplasmic antibody-associated vasculitis., PMID:40338657

The correlation between serum complement levels and clinical presentation in Egyptian immune thrombocytopenia patients., PMID:40327196

Clinical characterization of malignant lymphoma mimicking IgG4-related disease., PMID:40327158

Pregnancy-related Thrombotic Microangiopathy has a spectrum of underlying causes., PMID:40306205

Bartonella Endocarditis-Associated Glomerulonephritis: A Mimicker of Autoimmunity and Vasculitis., PMID:40303199

Neutrophil Z Is a Novel Marker to Differentiate Disease Flares From Bacterial Infections in Febrile SLE Patients., PMID:40302194

Complement dysregulation at lymphatics., PMID:40300720

The application of direct immunofluorescence in the pathological diagnosis of oral mucosal diseases: Series of 116 cases., PMID:40300523

B lymphocyte subset-based stratification in primary Sjögren's syndrome: implications for lymphoma risk and personalized treatment., PMID:40295463

Correlation of anti-phosphatidylethanolamine antibodies with premature birth in women with a history of miscarriage: a retrospective study., PMID:40288804

The Clinical and Laboratory Landscape of COVID-19 During the Initial Period of the Pandemic and at the Beginning of the Omicron Era., PMID:40284924

C3-Liposome Delivery of MUC1 Peptide and TLR Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences., PMID:40284463

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Mouse C3/Complement C3 Polyclonal Antibody [PMB89901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only